๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Due to neoadjuvant therapy with trastuzumab and pertuzumab is less effectiv...
Status
Unknown
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2023-04-15
Trial ID
NCT05430347
Treatments Being Tested
This is a prospective, multi-center, single-arm, phase 2 exploratory study ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-31
Trial ID
NCT07589699
Treatments Being Tested
The aim of this study is to evaluates the efficacy of weekly nab-paclitaxel...
Status
Recruiting
Location
Henan cancer hospital
Start Date
2020-09-18
Trial ID
NCT04547907
Treatments Being Tested
The aim of this study is to evaluate the efficacy of nab-paclitaxel (on day...
Status
Recruiting
Location
Henan cancer hospital
Start Date
2025-06-24
Trial ID
NCT07057427
Treatments Being Tested
In 2020, the incidence of breast cancer surpassed that of lung cancer for t...
Status
Withdrawn
Location
Henan cancer hospital
Start Date
2022-05-11
Trial ID
NCT05474690
This is an investigator-initiated randomized controlled, open-label, multic...
Status
Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2022-12-20
Trial ID
NCT05638594
The study is being conducted to evaluate the clinical efficacy of HLX87 in ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-27
Trial ID
NCT07294534
Treatments Being Tested
Due to the unique advantages of albumin-bound paclitaxel, several studies i...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-07-10
Trial ID
NCT05420454
To observe the efficiency for patient with stage II-III HR+/HER2+ early bre...
Status
Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2022-08-01
Trial ID
NCT05263570
Treatments Being Tested
This study is a phase III clinical trial to explore the efficacy and safety...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11-16
Trial ID
NCT07239271